| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |